JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on June 8, 2006; DOI: 10.1124/jpet.106.104810


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.104810v1
318/3/1240    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miles, K.
Right arrow Articles by Ritter, J. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miles, K.
Right arrow Articles by Ritter, J. K.


Received for publication March 22, 2006.
Revised June 7, 2006.
Accepted for publication June 7, 2006.

Adenovirus-mediated gene therapy to restore expression and functionality of multiple UDP-glucuronosyltransferase 1A enzymes in Gunn rat liver

Kristini Miles 1, Fay Kessler 1, Laura Webb 1, Philip C. Smith 2, Joseph K. Ritter 1*

1 Virginia Commonwealth University 2 University of North Carolina Chapel Hill

* Address correspondence to: E-mail: jkritter{at}vcu.edu

Abstract

The Gunn rat has been a valuable model for investigating the effect of UDP-glucuronosyltransferase 1A (UGT1A) deficiencies in drug metabolism and toxicity, but it is limited in some aspects. For example, the native Gunn rat model cannot distinguish between hepatic and extrahepatic UGT1A deficiencies in toxicological mechanisms. To extend the model's utility, we investigated the use of replication-defective recombinant UGT1A adenoviruses for the purpose of selectively restoring hepatic UGT1A function. Mycophenolic acid, the active metabolite of the anti-transplant rejection drug mycophenolate mofetil and suspected gastrointestinal toxicant, was used as a model UGT1A-dependent substrate. Treatment with UGT1A adenoviruses normalized the plasma mycophenolic acid and mycophenolic acid glucuronide concentration-time curves after mycophenolic acid administration (80 mg/kg, i.p.). Functional reconstitution was also apparent in the correction of the mycophenolic acid T1/2{alpha} and the AUCMPA,0-8hr:AUCMPAG,0-8hr ratio. Twenty-four hours post-mycophenolic acid, severe signs of toxicity were noted in the naive Gunn group including reduced food consumption. The effect on food consumption was reduced but not completely prevented in the UGT adenovirus-treated Gunns. In vitro analyses indicated adenovirus dose-dependent reconstitution of mycophenolic acid UGT activities and UGT1A contents in liver but not intestinal microsomes. In the highest adenovirus dose group, the liver microsomal UGT1A markers exceeded those of the heterozygote controls. The ability to selectively manipulate multiple hepatic UGT1A enzymes in Gunn rats should provide a novel way to assess the importance of intestinal or other extrahepatic UGT1A enzymes in toxicities induced by mycophenolic acid and other cytotoxic drugs and dietary agents.


Key words: UDP-glucuronosyltransferases, diarrhea, gastrointestinal toxicity, immunosuppressants, intestinal metabolism, mycophenolic acid





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.